Clinical Trials Logo

Metrorrhagia clinical trials

View clinical trials related to Metrorrhagia.

Filter by:

NCT ID: NCT01148420 Completed - Clinical trials for Dysfunctional Uterine Bleeding

DMPA & High Dose Oral Progestin (MPA) Tablets in Outpatient Treatment of Acute Excessive Vaginal Bleeding

Start date: January 2009
Phase: Phase 4
Study type: Interventional

The purpose of this study is to investigate the effectiveness and acceptability of high dose MPA (20mg oral 3 times a day) for 3 days combined with an injection of DMPA 150 mg intramuscularly in the treatment of acute heavy, prolonged uterine bleeding who have been identified as being eligible for outpatient management

NCT ID: NCT00563576 Completed - Metrorrhagia Clinical Trials

Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation

Start date: September 2007
Phase: N/A
Study type: Interventional

Many women choose Depo-Provera for birth control because it is easy to use and very effective. However, a significant number of Depo-Provera users experience irregular bleeding during the first 90 days. Many users discontinue after their first injection due to irregular bleeding. This study will evaluate the effect of using an estrogen vaginal ring during the first 90 days of Depo-Provera use to see if it is acceptable to women and whether it decreases irregular bleeding during the first 90 days of use and increases continuation to a second injection.

NCT ID: NCT00549159 Recruiting - Clinical trials for Dysfunctional Uterine Bleeding

CavatermTM vs TCRE in Women With DUB

Start date: October 2007
Phase: Phase 4
Study type: Interventional

The purpose of study is to compare the treatment success in the study groups.

NCT ID: NCT00475553 Completed - Clinical trials for Breakthrough Bleeding

Management of Breakthrough Bleeding During Extended Therapy Use With NuvaRing®

Start date: May 2006
Phase: N/A
Study type: Interventional

The purpose of this research study is to evaluate the best way to manage breakthrough spotting and bleeding during an extended use regimen of NuvaRing®. Ease of use and acceptability of a flexible regimen of NuvaRing® will also be evaluated. A comparison of cyclic mood symptoms, pelvic pain, and headaches will be made between a standard 21/7 regimen and an extended regimen.

NCT ID: NCT00394771 Completed - Clinical trials for Breakthrough Bleeding

A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale

Start date: October 2006
Phase: Phase 2
Study type: Interventional

This is a 4-arm study to evaluate and compare bleeding patterns between three different doses of DR-1031 oral contraceptive with Seasonale oral contraceptive. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a diary

NCT ID: NCT00344383 Completed - Metrorrhagia Clinical Trials

An Open-Label Study Evaluating Breakthrough Bleeding and Spotting With Norgestimate/Ethinyl Estradiol Tablets Administered as an Extended Regimen

Start date: November 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the bleeding profile of norgestimate/ethinyl estradiol, an oral contraceptive tablet, given in an extended regimen

NCT ID: NCT00320580 Completed - Metrorrhagia Clinical Trials

An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen

Start date: n/a
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the bleeding profile of norelgestromin/ethinyl estradiol given in an extended continuous regimen to norelgestromin/ethinyl estradiol given in a traditional cyclic regimen

NCT ID: NCT00307801 Completed - Metrorrhagia Clinical Trials

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Start date: February 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.

NCT ID: NCT00293059 Completed - Metrorrhagia Clinical Trials

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Start date: December 2005
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.

NCT ID: NCT00160381 Completed - Menorrhagia Clinical Trials

A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids

Start date: September 2002
Phase: Phase 3
Study type: Interventional

The objective of this study is to determine the safety and effectiveness of asoprisnil in symptomatic women with abnormal uterine bleeding associated with uterine fibroids.